Primary vesical sensory urgency. A clinical trial of bromocriptine.
A randomised double blind crossover trial of Bromocriptine against an inert placebo was performed in 14 patients with primary sensory urgency. Bromocriptine was found to have no therapeutic advantage for these patients and the possible explanations for this finding are discussed.
D001971:Bromocriptine / Q000009:adverse effects / Q000627:therapeutic use*; D002940:Circadian Rhythm; D002986:Clinical Trials as Topic; D004311:Double-Blind Method; D005260:Female; D006801:Humans; D010919:Placebos; D012677:Sensation / Q000187:drug effects; D013997:Time Factors; D001743:Urinary Bladder / Q000294:innervation; D001745:Urinary Bladder Diseases / Q000188:drug therapy*
D010919:Placebos; D001971:Bromocriptine